stoxline Quote Chart Rank Option Currency Glossary
Biotricity, Inc. (BTCY)
0.995  0.005 (0.51%)    12-05 14:35
Open: 1
High: 1.04
Volume: 18,743
Pre. Close: 0.99
Low: 0.9501
Market Cap: 9(M)
Technical analysis
2023-12-05 4:18:55 PM
Short term     
Mid term     
Targets 6-month :  1.41 1-year :  1.65
Resists First :  1.21 Second :  1.41
Pivot price 0.91
Supports First :  0.89 Second :  0.7
MAs MA(5) :  0.94 MA(20) :  0.9
MA(100) :  1.92 MA(250) :  1.23
MACD MACD :  -0.2 Signal :  -0.2
%K %D K(14,3) :  72.3 D(3) :  67.2
RSI RSI(14): 43.8
52-week High :  3.78 Low :  0.39
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ BTCY ] has closed below upper band by 12.4%. Bollinger Bands are 72.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.03 - 1.04 1.04 - 1.04
Low: 0.9 - 0.9 0.9 - 0.91
Close: 0.98 - 0.99 0.99 - 1
Company Description

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Headline News

Sun, 19 Nov 2023
Biotricity Second Quarter 2024 Earnings: US$0.44 loss per share (vs US$0.57 loss in 2Q 2023) - Simply Wall St

Thu, 16 Nov 2023
Biotricity, Inc. (NASDAQ:BTCY) Q2 2024 Earnings Call Transcript - Yahoo Finance

Tue, 31 Oct 2023
Biotricity Releases Another Groundbreaking Product: Biotres Pro - Yahoo Finance

Mon, 30 Oct 2023
Healthcare Stocks Making Moves Monday: MIRO, RVPH, EAR, BTAI, BTCY, APTO, ABVC, RVTY - InvestorsObserver

Fri, 27 Oct 2023
Healthcare Stocks Moving Up and Down Friday: IBRX, IPA, ZYXI, ACXP, VVOS, BTCY, PTCT, SNY - InvestorsObserver

Fri, 27 Oct 2023
Should You Accumulate Biotricity Inc (BTCY) in Medical Devices Industry? - InvestorsObserver

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical Devices
Shares Out 9 (M)
Shares Float 7 (M)
Held by Insiders 18.5 (%)
Held by Institutions 5.4 (%)
Shares Short 141 (K)
Shares Short P.Month 139 (K)
Stock Financials
EPS -1.97
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -3.03
Profit Margin -146.7 %
Operating Margin -75.6 %
Return on Assets (ttm) -99.1 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 21.3 %
Gross Profit (p.s.) 0
Sales Per Share 1.26
EBITDA (p.s.) -1.35
Qtrly Earnings Growth 0 %
Operating Cash Flow -9 (M)
Levered Free Cash Flow -1 (M)
Stock Valuations
PE Ratio -0.51
PEG Ratio 0
Price to Book value -0.33
Price to Sales 0.78
Price to Cash Flow -0.95
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android